Dermatological Aspects of COVID-19

Keywords: COVID 19, Immunomodulator, Skin lesions

Abstract

On 31 December 2019, Wuhan, the capital city of Hubei Province in China reported World Health Organization(WHO) about cases of pneumonia which were caused by a severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) currently designated coronavirus disease (COVID-19). The infection rapidly spread throughout the world escalating the situation and WHO eventually declared COVID-19 as a global pandemic on 11 March 2020. It has already affected almost all aspects of health and society globally. With the current pandemic, dermatologists should be aware of dermatological aspects of SARS-CoV-2, its skin manifestations and general skin care. 

Downloads

Download data is not yet available.

Author Biography

Alina Sharma, Palpa District Hospital, Palpa, Nepal.

Consultant Dermatologist.

References

World Health Organization. Naming the coronavirus disease (COVID-19) and the virus that causes it [Internet]. WHO: Geneva; 2020 [cited 2020 June 2] Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it

Phelan AL, Katz R, Gostin LO. The Novel Coronavirus Originating in Wuhan, China: Challenges for Global Health Governance. JAMA. 2020;323(8):709-10. PMID: 31999307. DOI: https://doi.org/10.1001/jama.2020.1097

World Health Organization. Coronavirus disease (COVID-19) Situation Report. WHO: Geneva; 2020. Situation report No.: 51. [cited 2020 May 25] Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200311-sitrep-51-covid-19.pdf?sfvrsn=1ba62e57_10

Recalcati S. Cutaneous manifestations in COVID‐19: a first perspective. Journal of The European Academy of Dermatology and Venereology. 2020;34(5):e212-e213. DOI: https://doi.org/10.1111/jdv.16387

Casas CG, Català A, Hernández GC, Rodríguez- Jiménez P, Nieto DF, Lario AR, et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. British Journal of Dermatology. Forthcoming 2020. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1111/bjd.19163

Sachdeva M, Gianotti R, Shah M, Lucia B, Tosi D, Veraldi S, et al. Cutaneous manifestations of COVID-19: Report of three cases and a review of literature. J Dermatol Sci. 2020;S0923- 1811(20)30149-3. PMID: 32381430. PMCID: PMC7189855. DOI: https://doi.org/10.1016/j.jdermsci.2020.04.011

Joob B, Wiwanitkit V. COVID-19 can present with a rash and be mistaken for dengue. J Am Acad Dermatol. 2020;82(5):e177. PMID: 32213305. PMCID: PMC156802. DOI: https://doi.org/10.1016/j.jaad.2020.03.036

Morand A, Urbina, D, Fabre A. COVID-19 and Kawasaki Like Disease: The Known-Known, the Unknown-Known and the Unknown- Unknown. Preprints. Forthcoming 2020. Available from: https://www.preprints.org/manuscript/202005.0160/v1

Rademaker M, Baker C, Foley P, Sullivan J, Wang C. Advice regarding COVID-19 and use of immunomodulators, in patients with severe dermatological diseases. Australas J Dermatol. 2020;61(2):158-59. PMID: 32219857. PMCID: PMC7228260. DOI: https://doi.org/10.1111/ajd.13295

American Academy of Dermatology. Guidance on the use of immunosuppressive agents [Internet]. United States: American Academy of Dermatology; 2020 [cited 2020 April 14]. Available from: www.aad.org/member/practice/coronavirus/clinical-guidance/biologics

British Association of Dermatologist. Dermatology Advice Regarding Self-Isolation and Immunosuppressed Patients: Adults, Paediatrics and Young People [Internet]. London: British Association of Dermatologists; 2020 [cited 2020 may 25]. Available from: https://www.bad.org.uk/healthcare-professionals/covid-19/covid-19-%20immunosuppressed-patients.

Consensus/Policy of SODVELON on current COVID-19 crisis [Internet] 1st published 15th April 2020. Nepal: Society Of Dermatologists Venereologist and Leprologists, 2020 [cited 2020 June 9] Available from: https://docs.google.com/viewerng/viewer?url=http://sodvelon.com/wp-content/uploads/2020/04/covid-19-SODVELON-statement-for-Dermatological-and-cosmetic-practice-final.pdf

Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster. Lancet. 2020;395(10223):514-23. PMID: 31986261. PMCID: PMC7159286. DOI: https://doi.org/10.1016/s0140-6736(20)30154-9.T

Toncic RJ, Jakasa I, Hadzavdic SL, Goorden SM, Vlugt KJG, Stet FS, et al. Altered Levels of Sphingosine, Sphinganine and Their Ceramides in Atopic Dermatitis Are Related to Skin Barrier Function, Disease Severity and Local Cytokine Milieu. Int J Mol Sci. 2020;21(6):1958. PMID: 32183011. PMCID: PMC7139865. DOI: https://doi.org/10.3390/ijms21061958

Pei S, Xue Y, Zhao S, Alexander N, Mohamad G, Chen X, et al. Occupational skin conditions on the frontline: A survey among 484 Chinese healthcare professionals caring for Covid-19 patients. J Eur Acad Dermatol Venereol. 2020; [Epub ahead of print]. PMID: 32362062. PMCID: PMC7267162. DOI: https://doi.org/10.1111/jdv.16570

Lan J, Song Z, Miao X, Li H, Li Y, Dong L, et al. Skin damage among health care workers managing coronavirus disease-2019. J Am Acad Dermatol. 2020;82(5):1215-16. PMID: 32171808. PMCID: PMC7194538. DOI: https://doi.org/10.1016/j.jaad.2020.03.014

Jagadeesan S, Sarkar R. COVID-19 and the dermatologist: finding calm in the chaos. Pigment Int. 2020; [Epub ahead of print]. DOI: https://doi.org/10.4103/Pigmentinternational.Pigmentinternational_24_20

Published
2020-06-21
How to Cite
1.
Sharma A. Dermatological Aspects of COVID-19. J Lumbini Med Coll [Internet]. 21Jun.2020 [cited 9Jul.2020];8(1):4 pages. Available from: https://jlmc.edu.np/index.php/JLMC/article/view/379
Section
Perspective